To verify the relationship between RAPGEF2 and CD56+ NK cells in HCC, we found knockdown RAPGEF2 in HCC cells reduces tumor infiltrating CD56+ NK cell recruitment in MHCC97 xenograft tumors (Figures 3(d) and 3(e)). The gene discussed is NCAM1; the disease is hepatocellular carcinoma.